GlassScriptPhysician profile
Dana Hensley
NPI 1952612442
$6,320.01
in general payments reported to CMS, 2019-2025
15 companies · $723 in 2025
The $723 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $186 · 2021: $156 · 2022: $366 · 2023: $570 · 2024: $4,022 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,019 · Food and Beverage: $2,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,019.13 |
| Food and Beverage | $2,295.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,980.76 | 2022-2025 | Microraptor, Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Arthrex, INC. | $1,143.19 | 2021-2024 | |
| Stryker Corporation | $692.11 | 2019-2025 | Pangea, Gamma, T2 Alpha |
| United Orthopedics LLC | $460.71 | 2024 | |
| Zimmer Biomet Holdings, INC. | $366.22 | 2022-2025 | Tapestry |
| Vericel Corporation | $230.46 | 2020-2021 | |
| Amgen INC. | $104.16 | 2024 | |
| Convatec INC. | $72.73 | 2019 | |
| Ossdsign USA Incorporated | $66.61 | 2025 | Ossdsign Catalyst |
| Bioventus LLC | $65.74 | 2019 | |
| Ferring Pharmaceuticals INC. | $42.89 | 2023-2024 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $29.82 | 2025 | |
| Acera Surgical, INC. | $24.66 | 2025 | Restrata Wound Matrix |
| Laborie Medical Technologies Corp. | $22.88 | 2024 | Endosheath Technology |
| Moximed, INC | $17.07 | 2025 | Misha Knee System, Small, Left |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Hensley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.